24.09.2021 19:58

EXPLAINER: Who's eligible for Pfizer booster shots in US?

Folgen
Werbung
Millions of Americans are now eligible to receive a Pfizer booster shot to help increase their protection against the worst effects of the coronavirus.A look at the nuts and bolts of this new phase of the vaccination campaign:WHO SHOULD GET THE PFIZER BOOSTER?People who got two Pfizer shots at least six months ago and who fall into one of these groups should get the booster:— People 65 and older, nursing home residents and assisted living residents.— Others ages 50 to 64 with a long list of risky health problems including cancer, diabetes, asthma, HIV infection and heart disease. Being overweight or obese is a category that qualifies roughly 70% of people in this age group.WHO ELSE CAN CONSIDER GETTING IT?The Centers for Disease Control and Prevention says these people may get a booster, but stopped short of a full recommendation:— People 18 to 49 who got their Pfizer shots at least six months ago with risky health problems can consider the booster based on their individual benefits and risks.— Anyone 18 to 64 with a risky job, such as health care, can consider boosters. Prisoners and people living in homeless shelters are also in this group.WHAT ARE THE SIDE EFFECTS?Serious side effects from the first two Pfizer doses are exceedingly rare, including heart inflammation that sometimes occurs in younger men. WEREN’T SOME PEOPLE ALREADY ELIGIBLE FOR A THIRD DOSE?Yes, people with severely weakened immune systems were already eligible to get a third dose of Pfizer or Moderna. This group includes people taking immune-suppressing medications and those with diseases that tamp down their immune systems. They didn’t have to wait six months to get a third dose. WHAT IF I GOT MODERNA? CAN I GET A PFIZER BOOSTER?Not yet. Health officials say they don’t have enough data on mix-and-match vaccinations. Moderna has applied to U.S. health regulators for its own booster, one that would be half the dose of the original shots. The Food and Drug Administration is considering that application. WHAT IF I GOT J&J?People who originally got the single-dose Johnson & Johnson also must wait. The government doesn’t recommend mixing-and-matching. J&J hasn’t yet filed a booster application. But earlier this week, the company released data showing two doses of its vaccine provided stronger immunity than one — whether the extra dose was given either two months or six months after the first.WHERE CAN I GET MY BOOSTER?Health departments, clinics and drugstores are offering boosters, and many people have already gotten them ahead of the official green light. You may have to show your vaccine card. Proving how you qualify is on the honor system. Your word about your risky job or health condition is likely to be enough.ARE BOOSTERS FREE?Yes, shots given under FDA’s emergency use authorization are free. And there should be enough supplies.AM I ‘FULLY VACCINATED’ WITHOUT A BOOSTER?Yes, two doses of Pfizer or Moderna, or one of J&J, is still considered fully vaccinated.WHY WERE BOOSTERS SO HOTLY DEBATED?The need is not crystal clear. Studies show the vaccines are still offering strong protection against serious illness for all ages. And many experts want to focus attention on getting shots to the unvaccinated, the group most in danger of infection, hospitalization and death.On the other hand, there is a slight drop in the vaccine’s effectiveness among the oldest adults. And immunity against milder infection appears to wane months after people’s initial shots. Protecting health care workers from even mild illness may help some hospitals now struggling to care for unvaccinated COVID-19 patients.ARE OTHER COUNTRIES OFFERING BOOSTERS?Britain and Israel are already giving boosters over strong objections from the World Health Organization that poor countries don’t have enough for their initial doses.___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.???? EXPLAINER: Who's eligible for Pfizer booster shots in US? ????? The China Post, Taiwan?
Weiter zum vollständigen Artikel bei "Chinapost"
Quelle: EN, Chinapost

Nachrichten zu Pfizer Inc.

  • Relevant
    1
  • Alle
    1
  • vom Unternehmen
  • Peer Group
  • ?

Um Ihnen die Übersicht über die große Anzahl an Nachrichten, die jeden Tag für ein Unternehmen erscheinen, etwas zu erleichtern, haben wir den Nachrichtenfeed in folgende Kategorien aufgeteilt:

Relevant: Nachrichten von ausgesuchten Quellen, die sich im Speziellen mit diesem Unternehmen befassen

Alle: Alle Nachrichten, die dieses Unternehmen betreffen. Z.B. auch Marktberichte die außerdem auch andere Unternehmen betreffen

vom Unternehmen: Nachrichten und Adhoc-Meldungen, die vom Unternehmen selbst veröffentlicht werden

Peer Group: Nachrichten von Unternehmen, die zur Peer Group gehören

Analysen zu Pfizer Inc.

  • Alle
  • Buy
  • Hold
  • Sell
  • ?
29.07.2021Pfizer NeutralGoldman Sachs Group Inc.
29.07.2021Pfizer Sector PerformRBC Capital Markets
15.06.2021Pfizer HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
24.05.2021Pfizer NeutralJP Morgan Chase & Co.
24.05.2021Pfizer NeutralGoldman Sachs Group Inc.
03.02.2021Pfizer kaufenDZ BANK
02.12.2020Pfizer OutperformRBC Capital Markets
16.10.2020Pfizer OutperformRBC Capital Markets
09.09.2020Pfizer OutperformRBC Capital Markets
20.07.2020Pfizer OutperformRBC Capital Markets
29.07.2021Pfizer NeutralGoldman Sachs Group Inc.
29.07.2021Pfizer Sector PerformRBC Capital Markets
15.06.2021Pfizer HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
24.05.2021Pfizer NeutralJP Morgan Chase & Co.
24.05.2021Pfizer NeutralGoldman Sachs Group Inc.
03.05.2018Pfizer VerkaufenDZ BANK
16.05.2017Pfizer SellCitigroup Corp.
27.11.2012Pfizer verkaufenHamburger Sparkasse AG (Haspa)
28.08.2012Pfizer verkaufenHamburger Sparkasse AG (Haspa)
10.01.2012Pfizer verkaufenHamburger Sparkasse AG (Haspa)

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Pfizer Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"

Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"

Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen

Jetzt noch kostenlos anmelden!

Im B2B-Seminar am Montag um 11 Uhr zeigen Ihnen die Investment-Experten Victoria Arnold und Dr. Manuel Bermes den neuen Anlagestandard in Krisenzeiten für mehr Rendite und Stabilität Ihres ETF-Portfolios.
Jetzt kostenlos anmelden!
Werbung
Werbung
Werbung
Werbung
Börse Stuttgart Anlegerclub
Werbung

Heute im Fokus

US-Börsen letztlich uneins -- DAX geht stärker ins Wochenende -- Continental senkt Ausblick 2021 -- Snap enttäuscht Anleger -- Intel steigert Umsatz und Gewinn -- Evergrande, American Express im Fokus

Powell: Drosselung der Anleihekäufe sollte Mitte 2022 abgeschlossen sein. Goldman gewährt CEO Solomon und President Waldron einmaligen Bonus. Facebook schließt Lizenz-Vereinbarung mit französischen Verlagen. Honeywell senkt Umsatzprognose 2021. Schlumberger kehrt mit Wachstum deutlich in die Gewinnzone zurück. Siemens Energy zieht sich aus Wasserkraft-JV mit Voith zurück.

Umfrage

Wo steht der DAX zum Jahresende?

finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln